Abstract

PI3Kγ, a G-protein-coupled type 1B phosphoinositol 3-kinase, exhibits a basal glucose-independent activity in β-cells and can be activated by the glucose-dependent insulinotropic polypeptide (GIP). We therefore investigated the role of the PI3Kγ catalytic subunit (p110γ) in insulin secretion and β-cell exocytosis stimulated by GIP. We inhibited p110γ with AS604850 (1 μmol/liter) or knocked it down using an shRNA adenovirus or siRNA duplex in mouse and human islets and β-cells. Inhibition of PI3Kγ blunted the exocytotic and insulinotropic response to GIP receptor activation, whereas responses to the glucagon-like peptide-1 or the glucagon-like peptide-1 receptor agonist exendin-4 were unchanged. Downstream, we find that GIP, much like glucose stimulation, activates the small GTPase protein Rac1 to induce actin remodeling. Inhibition of PI3Kγ blocked these effects of GIP. Although exendin-4 could also stimulate actin remodeling, this was not prevented by p110γ inhibition. Finally, forced actin depolymerization with latrunculin B restored the exocytotic and secretory responses to GIP during PI3Kγ inhibition, demonstrating that the loss of GIP-induced actin depolymerization was indeed limiting insulin exocytosis.

Highlights

  • PI3K␥ is implicated in insulin secretion and actin remodeling and is activated by glucose-dependent insulinotropic polypeptide (GIP)

  • We demonstrate that pharmacological inhibition, or shRNA-mediated knockdown of p110␥ impairs the insulinotropic effect of GIP-R activation in mouse and human islets

  • P110␥ Is Required for GIP-R-dependent Actin Depolymerization—Because p110␥ inhibition prevents the insulinotropic effect of GIP and cortical actin dynamics are essential to insulin secretion [34], we investigated the role of p110␥ in GIP-induced actin depolymerization

Read more

Summary

Background

PI3K␥ is implicated in insulin secretion and actin remodeling and is activated by glucose-dependent insulinotropic polypeptide (GIP). Forced actin depolymerization with latrunculin B restored the exocytotic and secretory responses to GIP during PI3K␥ inhibition, demonstrating that the loss of GIP-induced actin depolymerization was limiting insulin exocytosis. Both rodent and human ␤-cells express G-protein-coupled receptors that are activated by peptide hormones of the secretin family: glucose-dependent insulinotropic peptide (GIP) and. We demonstrate that pharmacological inhibition, or shRNA-mediated knockdown of p110␥ impairs the insulinotropic effect of GIP-R (but not GLP-1-R) activation in mouse and human islets. We demonstrate that in addition to the classical cAMP pathway, PI3K signaling through p110␥ is required for the full insulinotropic effect of GIP

EXPERIMENTAL PROCEDURES
RESULTS
C Mouse β-cells
G Mouse β-cells
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call